It is currently Mon Jul 28, 2014 9:43 am

News News of Copaxone

Site map of Copaxone » Forum : Copaxone

A board to discuss the Multiple Sclerosis modifying drug Copaxone

Generics, 40 mg. Copaxone and Teva

Interesting week trying to get Jeff's Copaxone 20mg. refilled. Has this happened to anyone else??

Accredo giving us the run around, wouldn't fill prescription. Said we'd missed the "one day prior authorization cut off" ???
After spending all morning on the phone with insurance, neuro and the pharmacy----I think I know what's going on.

Teva does not want to lose business with all the new generics.
The stand to lose a half billion dollars.
Generic ...
Read more : Generics, 40 mg. Copaxone and Teva | Views : 2267 | Replies : 22


FDA approves three-times-a-week Copaxone

Teva Pharmaceutical Industries Ltd. has announced that the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental new drug application (sNDA) for three-times-a-week Copaxone 40mg/mL, a new dose of Copaxone . This new formulation will allow for a less frequent dosing regimen administered subcutaneously for patients with relapsing forms of multiple sclerosis (MS). In addition to the newly approved dose, daily Copaxone 20 mg/mL will continue to be available. The daily subcutaneous injection ...
Read more : FDA approves three-times-a-week Copaxone | Views : 793 | Replies : 3


No mri lesions..ms?

Hi..I am neg lyme and lupus with many MS symptoms. Buzzing sensation left leg, black hole in vision, burning sensation left neck and back, foggy headed, feel bruised on left arm but no bruising. Neuro said non contrast brain mri was clean so it cannot be MS. Can I have cognitive issues if there are lesions on spine and not brain? He did not seem to think further testing is necessary but did not have ...
Read more : No mri lesions..ms? | Views : 507 | Replies : 3


Teva licenses glatiramer acetate to Takeda in Japan

Teva Pharmaceutical has licensed rights to commercialize glatiramer acetate to Takeda Pharmaceutical in Japan as part of their agreement signed earlier in 2013.<br><br>

Currently both the firms are working on additional agreements for implementation of the license..... Read More - http://www.ms-uk.org/copaxone
Read more : Teva licenses glatiramer acetate to Takeda in Japan | Views : 655 | Replies : 1


anyone on copaxone with kaiser health insurance?

so i have to choose a new health plan since i have a new job and one of the plans is kaiser. it has been very difficult to find out how much the plan will cover for copaxone. i have been told multiple different prices for a monthly copay as well as been transferred around way too many times and i still don't have a straight answer. i know that i will probably not be ...
Read more : anyone on copaxone with kaiser health insurance? | Views : 645 | Replies : 3


Copaxone in Singapore as an Australian

Hi everyone,

One of my family members has MS and in Australia he comes under our Pharmaceutical Benefits Scheme, so Copaxone is affordable. He is moving to Singapore for two years however and I was wondering whether anyone has any experience as an Australian moving overseas with MS and how you went about it in terms of being able to afford the drug.

Thanks very much in advance for your time.

Amy
Read more : Copaxone in Singapore as an Australian | Views : 541 | Replies : 0


Copaxone

Hi everyone,

A family member of mine has MS and comes under the Pharmaceutical Benefits Scheme in Australia, therefore his copaxone is subsidised to a manageable level. He is moving to Singapore however and can't quite work out how to work it without having to come back to Australia every 6 months. Does anyone have any experience in this situation?

Thank you for your time.
Read more : Copaxone | Views : 472 | Replies : 0


Mapi pharma patents new MS drug

Once-a-month treatment for multiple sclerosis gains US patent – inching Israeli pharma company closer to the market.

Only three years after going into business in Ness Ziona, Israel, Mapi Pharma has won a US patent for a promising drug in its pipeline – a slow-release form of glatiramer acetate for treating multiple sclerosis (MS) symptoms just once a month.....Read More - http://www.ms-uk.org/copaxone
Read more : Mapi pharma patents new MS drug | Views : 724 | Replies : 0


Teva rejected by U.S. high court justice on Copaxone patent

Pharmaceutical Industries Ltd.’s Copaxone multiple-sclerosis drug to generic competition in May.

The lower court ruling invalidated one of the company’s patents and shaved more than a year off the legal protection for Copaxone, a treatment that generated $2.25 billion in U.S. sales for Teva in 2011. Chief Justice John Roberts today rejected Teva’s request to put that ruling on hold while the court decides whether to take up Teva’s appeal...... Read More - http://www.ms-uk.org/copaxone
Read more : Teva rejected by U.S. high court justice on Copaxone patent | Views : 552 | Replies : 0


Glatiramer acetate treatment effects on gene expression.....

Glatiramer acetate treatment effects on gene expression in monocytes of MS patients

Glatiramer acetate (GA) is a mixture of synthetic peptides used in the treatment of patients with relapsing-remitting multiple sclerosis (RRMS). The aim of this study was to investigate the effects of GA therapy on the gene expression of monocytes........ Read More - http://www.ms-uk.org/copaxone
Read more : Glatiramer acetate treatment effects on gene expression..... | Views : 660 | Replies : 0


 

Login  •  Register


Statistics

Total posts 218722 • Total topics 22544 • Total members 14189